Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril for Asymptomatic Heart Failure in Women
NCT06341101Phase 4Recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Mar 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of perindopril in heart failure (HF), diastolic dysfunction, sponsored by Maastricht University Medical Center+. Started Mar 2024; status: recruiting.
02
Drugs
perindopril
03
Conditions
heart failure (HF)diastolic dysfunction
Beyond the preview
Go deeper on NCT06341101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06341101.